These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 18816045)

  • 41. Synthesis and evaluation of mansonone F derivatives as topoisomerase inhibitors.
    Wu WB; Ou JB; Huang ZH; Chen SB; Ou TM; Tan JH; Li D; Shen LL; Huang SL; Gu LQ; Huang ZS
    Eur J Med Chem; 2011 Aug; 46(8):3339-47. PubMed ID: 21600681
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design, synthesis and evaluation of isaindigotone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors.
    Pan L; Tan JH; Hou JQ; Huang SL; Gu LQ; Huang ZS
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3790-3. PubMed ID: 18524585
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design, synthesis, inhibitory activity, and SAR studies of hydrophobic p-aminosalicylic acid derivatives as neuraminidase inhibitors.
    Zhang J; Wang Q; Fang H; Xu W; Liu A; Du G
    Bioorg Med Chem; 2008 Apr; 16(7):3839-47. PubMed ID: 18304821
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Convenient synthesis of indeno[1,2-c]isoquinolines as constrained forms of 3-arylisoquinolines and docking study of a topoisomerase I inhibitor into DNA-topoisomerase I complex.
    Van HT; Le QM; Lee KY; Lee ES; Kwon Y; Kim TS; Le TN; Lee SH; Cho WJ
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5763-7. PubMed ID: 17827007
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and biological evaluation of rhodanine derivatives as PRL-3 inhibitors.
    Ahn JH; Kim SJ; Park WS; Cho SY; Ha JD; Kim SS; Kang SK; Jeong DG; Jung SK; Lee SH; Kim HM; Park SK; Lee KH; Lee CW; Ryu SE; Choi JK
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2996-9. PubMed ID: 16530413
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Study of an unexpected rearrangement of the alpha-phenyl pyrane derivatives prepared via hetero-Diels-Alder reaction of acyclic vinyl allenes and aldehydes.
    Ruiz JM; Regás D; Afonso MM; Palenzuela JA
    J Org Chem; 2008 Sep; 73(18):7246-54. PubMed ID: 18707174
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis, biological activity, and molecular modeling studies of 1H-1,2,3-triazole derivatives of carbohydrates as alpha-glucosidases inhibitors.
    Ferreira SB; Sodero AC; Cardoso MF; Lima ES; Kaiser CR; Silva FP; Ferreira VF
    J Med Chem; 2010 Mar; 53(6):2364-75. PubMed ID: 20170190
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular modelling studies, synthesis and biological activity of a series of novel bisnaphthalimides and their development as new DNA topoisomerase II inhibitors.
    Filosa R; Peduto A; Micco SD; Caprariis Pd; Festa M; Petrella A; Capranico G; Bifulco G
    Bioorg Med Chem; 2009 Jan; 17(1):13-24. PubMed ID: 19058969
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro assessment of novel transcription inhibitors and topoisomerase poisons in rhabdomyosarcoma cell lines.
    Wolf SJ; Wakelin LP; He Z; Stewart BW; Catchpoole DR
    Cancer Chemother Pharmacol; 2009 Nov; 64(6):1059-69. PubMed ID: 19277661
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis of 2,3-disubstituted 1,4-naphthoquinones as antiplatelet agents.
    Lien JC; Wu CR; Hour MJ; Huang LJ; Huang TF; Kuo SC
    Arch Pharm (Weinheim); 2008 Oct; 341(10):639-44. PubMed ID: 18720342
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Computer-aided design and synthesis of nonpeptidic plasmepsin II and IV inhibitors.
    Luksch T; Chan NS; Brass S; Sotriffer CA; Klebe G; Diederich WE
    ChemMedChem; 2008 Sep; 3(9):1323-36. PubMed ID: 18752222
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Naphthofuroquinone derivatives: inhibition of receptor tyrosine kinases.
    Lee KI; Park Y; Park SJ; Hwang JH; Lee SJ; Kim GD; Park WK; Lee S; Jeong D; Kong JY; Kang HK; Cho H
    Bioorg Med Chem Lett; 2006 Feb; 16(3):737-42. PubMed ID: 16321529
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design, synthesis, and biological testing of novel naphthoquinones as substrate-based inhibitors of the quinol/fumarate reductase from Wolinella succinogenes.
    Nasiri HR; Madej MG; Panisch R; Lafontaine M; Bats JW; Lancaster CR; Schwalbe H
    J Med Chem; 2013 Dec; 56(23):9530-41. PubMed ID: 24251984
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development and evaluation of a pharmacophore model for inhibitors of aldosterone synthase (CYP11B2).
    Ulmschneider S; Negri M; Voets M; Hartmann RW
    Bioorg Med Chem Lett; 2006 Jan; 16(1):25-30. PubMed ID: 16246562
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design, synthesis, and biological evaluation of cytotoxic 11-aminoalkenylindenoisoquinoline and 11-diaminoalkenylindenoisoquinoline topoisomerase I inhibitors.
    Xiao X; Antony S; Kohlhagen G; Pommier Y; Cushman M
    Bioorg Med Chem; 2004 Oct; 12(19):5147-60. PubMed ID: 15351398
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Solid phase combinatorial synthesis of benzothiazoles and evaluation of topoisomerase II inhibitory activity.
    Choi SJ; Park HJ; Lee SK; Kim SW; Han G; Choo HY
    Bioorg Med Chem; 2006 Feb; 14(4):1229-35. PubMed ID: 16242334
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Convergent synthesis and cruzain inhibitory activity of novel 2-(N'-benzylidenehydrazino)-4-trifluoromethyl-pyrimidines.
    Zanatta N; Amaral SS; Dos Santos JM; de Mello DL; Fernandes Lda S; Bonacorso HG; Martins MA; Andricopulo AD; Borchhardt DM
    Bioorg Med Chem; 2008 Dec; 16(24):10236-43. PubMed ID: 18996017
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Design, synthesis, and biological evaluation of phosphoramide derivatives as urease inhibitors.
    Domínguez MJ; Sanmartín C; Font M; Palop JA; San Francisco S; Urrutia O; Houdusse F; García-Mina J
    J Agric Food Chem; 2008 May; 56(10):3721-31. PubMed ID: 18452297
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design, docking, and synthesis of novel indeno[1,2-c]isoquinolines for the development of antitumor agents as topoisomerase I inhibitors.
    Cho WJ; Le QM; My Van HT; Youl Lee K; Kang BY; Lee ES; Lee SK; Kwon Y
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3531-4. PubMed ID: 17498951
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular design, synthesis and docking study of benz[b]oxepines and 12-oxobenzo[c]phenanthridinones as topoisomerase 1 inhibitors.
    Lee SH; Van HT; Yang SH; Lee KT; Kwon Y; Cho WJ
    Bioorg Med Chem Lett; 2009 May; 19(9):2444-7. PubMed ID: 19345580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.